Boehringer Ingelheim Launches Hepatitis C Web Portal for Patients, Health Care Providers
January 17, 2013
The pharmaceutical company Boehringer Ingelheim recently launched the website www.HepCRedefined.com to provide resources and tools for individuals infected with the hepatitis C virus (HCV). The company collaborated with HCV community advocates and healthcare providers to create the portal, which offers a range of interactive tools and information that can be shared through social media channels, placed on other websites, or viewed on various smart devices. Michael Ninburg, executive director of the Hepatitis Education Project, states that "HepCRedefined.com is designed to aggregate straightforward and accurate information in a single, virtual destination." CDC estimates the United States recorded 16,000 cases of acute HCV and 3.2 million individuals with chronic HCV infection in 2009.
Gastroenterology & Endoscopy News
This article was provided by CDC National Prevention Information Network. It is a part of the publication CDC HIV/Hepatitis/STD/TB Prevention News Update.
Add Your Comment:
(Please note: Your name and comment will be public, and may even show up in
Internet search results. Be careful when providing personal information! Before
adding your comment, please read TheBody.com's Comment Policy.)